Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Sotio Biotech Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Bayer
Stanford University
Merck Sharp & Dohme LLC
ViroMissile, Inc.
Tizona Therapeutics, Inc
MacroGenics
City of Hope Medical Center
Novartis
University of Southern California
Innate Pharma
Novartis
OncoNano Medicine, Inc.
Compass Therapeutics
The First Affiliated Hospital of Xinxiang Medical College
NeoTX Therapeutics Ltd.
Abramson Cancer Center at Penn Medicine
Bolt Biotherapeutics, Inc.
AstraZeneca
Actym Therapeutics, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Valo Therapeutics Oy
Memgen, Inc.
Numab Therapeutics AG
University of Virginia
Genentech, Inc.
Eli Lilly and Company
Novartis
Shandong Boan Biotechnology Co., Ltd
M.D. Anderson Cancer Center
Theratechnologies
Tvardi Therapeutics, Incorporated
Turnstone Biologics, Corp.
Seagen Inc.
National Cancer Institute (NCI)
Eli Lilly and Company
Vincerx Pharma, Inc.
AstraZeneca
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
NantBioScience, Inc.
Xencor, Inc.
Gene Surgery LLC
Pfizer
ADC Therapeutics S.A.
Pliant Therapeutics, Inc.